PHARMACOKINETICS OF 4'EPI-DOXORUBICIN AFTER INTRAVENOUS AND INTRAVESICAL ADMINISTRATION

被引：0
|
作者：
VANDERVIJGH, WJF
WEENEN, H
OSTEROP, A
VANDERPOORT, SEJM
KURTH, KK
BOGDANOWICZ, JF
PINEDO, HM
机构：
[1] FREE UNIV HOSP AMSTERDAM,DEPT ONCOL,1081 HV AMSTERDAM,NETHERLANDS
[2] ERASMUS UNIV,DEPT UROL,3000 DR ROTTERDAM,NETHERLANDS
来源：
BRITISH JOURNAL OF CANCER | 1985年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：463 / 464
页数：2
相关论文
共 50 条
  • [11] PHARMACOKINETICS OF 4'EPI-ADRIAMYCIN AFTER MORNING AND AFTERNOON INTRAVENOUS ADMINISTRATION
    EKSBORG, S
    STENDAHL, U
    ANTILA, K
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1989, 6 (03): : 195 - 197
  • [12] A PHASE-II STUDY OF 4'-EPI-DOXORUBICIN
    CAMPORA, E
    VINCI, P
    VISCHI, M
    SERTOLI, MR
    NOBILE, MT
    FELETTI, R
    GANZINA, F
    ROSSO, R
    CHEMIOTERAPIA, 1983, 2 (04): : 226 - 231
  • [13] PHASE-II STUDY OF 4 EPI-DOXORUBICIN
    FERRAZZI, E
    NICOLETTO, O
    VINANTE, O
    PAGNIN, P
    MARAGLINO, G
    GANZINA, F
    FIORENTINO, MV
    TUMORI, 1982, 68 (05) : 431 - 435
  • [14] LACK OF MUTAGENICITY BY DOXORUBICIN, 4'-EPI-DOXORUBICIN AND 4'-DEOXYDOXORUBICIN IN HUMAN-CELLS
    FERRERI, AM
    CAPUCCI, A
    GRILLI, MP
    ROCCHI, P
    PEROCCO, P
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (09): : 1284 - 1284
  • [15] PRELIMINARY ECHOCARDIOGRAPHIC AND POLYGRAPHIC EVALUATION OF CARDIAC TOXICITY OF 4'-EPI-DOXORUBICIN
    VILLANI, F
    COMAZZI, R
    LACAITA, G
    GENITONI, V
    GUINDANI, A
    MARTINI, A
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1983, 21 (04) : 203 - 208
  • [16] PHASE-II TRIAL OF 4'-EPI-DOXORUBICIN IN METASTATIC MELANOMA
    TORTI, FM
    PORZIG, KJ
    GANDARA, DR
    VOLBERDING, P
    MITCHELL, E
    MEYERS, FJ
    KOHLER, M
    GRIBBLE, M
    CANCER TREATMENT REPORTS, 1984, 68 (12): : 1509 - 1510
  • [17] PHASE-II CLINICAL-EVALUATION OF 4'-EPI-DOXORUBICIN
    HURTELOUP, P
    CAPPELAERE, P
    ARMAND, JP
    MATHE, G
    CANCER TREATMENT REPORTS, 1983, 67 (04): : 337 - 341
  • [18] Inhibition of NO synthase induction by an anticancer drug 4'-epi-doxorubicin in rats
    Sakai, T
    Muramatsu, I
    Hayashi, N
    Ishii, Y
    GENERAL PHARMACOLOGY, 1996, 27 (08): : 1367 - 1372
  • [19] ACTIVITY OF 4'-EPI-DOXORUBICIN ON NORMAL HEMATOPOIETIC PRECURSOR CELLS IN MICE
    SOBRERO, A
    MUZZULINI, C
    DAMORE, F
    BOGLIOLO, G
    MASSA, G
    GHIO, R
    PANNACCIULLI, I
    CANCER TREATMENT REPORTS, 1982, 66 (12): : 2061 - 2070
  • [20] 4'-EPI-DOXORUBICIN IN COMBINATION WITH CISPLATIN IN ADVANCED OVARIAN-CANCER
    MARTONI, A
    TOMASI, L
    FARABEGOLI, G
    FRUET, F
    PANNUTI, F
    CANCER TREATMENT REPORTS, 1984, 68 (11): : 1391 - 1393
12345